1. Home
  2. ABEO vs PNRG Comparison

ABEO vs PNRG Comparison

Compare ABEO & PNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • PNRG
  • Stock Information
  • Founded
  • ABEO 1974
  • PNRG 1973
  • Country
  • ABEO United States
  • PNRG United States
  • Employees
  • ABEO N/A
  • PNRG N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • PNRG Oil & Gas Production
  • Sector
  • ABEO Health Care
  • PNRG Energy
  • Exchange
  • ABEO Nasdaq
  • PNRG Nasdaq
  • Market Cap
  • ABEO 281.0M
  • PNRG 252.3M
  • IPO Year
  • ABEO 1980
  • PNRG N/A
  • Fundamental
  • Price
  • ABEO $4.36
  • PNRG $133.40
  • Analyst Decision
  • ABEO Strong Buy
  • PNRG
  • Analyst Count
  • ABEO 5
  • PNRG 0
  • Target Price
  • ABEO $18.20
  • PNRG N/A
  • AVG Volume (30 Days)
  • ABEO 1.5M
  • PNRG 133.2K
  • Earning Date
  • ABEO 11-13-2025
  • PNRG 11-14-2025
  • Dividend Yield
  • ABEO N/A
  • PNRG N/A
  • EPS Growth
  • ABEO N/A
  • PNRG N/A
  • EPS
  • ABEO 0.99
  • PNRG 14.88
  • Revenue
  • ABEO $400,000.00
  • PNRG $218,319,000.00
  • Revenue This Year
  • ABEO N/A
  • PNRG N/A
  • Revenue Next Year
  • ABEO $324.71
  • PNRG N/A
  • P/E Ratio
  • ABEO $4.41
  • PNRG $8.95
  • Revenue Growth
  • ABEO N/A
  • PNRG 22.17
  • 52 Week Low
  • ABEO $3.93
  • PNRG $126.40
  • 52 Week High
  • ABEO $7.54
  • PNRG $243.49
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 24.72
  • PNRG 35.77
  • Support Level
  • ABEO $5.29
  • PNRG $130.70
  • Resistance Level
  • ABEO $5.41
  • PNRG $138.03
  • Average True Range (ATR)
  • ABEO 0.24
  • PNRG 7.63
  • MACD
  • ABEO -0.08
  • PNRG -1.80
  • Stochastic Oscillator
  • ABEO 3.49
  • PNRG 19.32

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About PNRG PrimeEnergy Resources Corporation

PrimeEnergy Resources Corp is an independent oil and natural gas company that is engaged in acquiring, developing, and producing oil and natural gas. It owns producing and non-producing properties located in Texas and Oklahoma. The company's business activities include development and exploratory drilling and providing well servicing support operations for many of the onshore oil and gas wells through its subsidiaries. It is also active in the acquisition of producing oil and gas properties through joint ventures with industry partners.

Share on Social Networks: